GLOBAL MARKETS-Global equities hover near record highs as stimulus hopes build

World equity benchmarks hovered record highs and the dollar edged off of 2-1/2-year lows on Wednesday as investors weighed the first approval of a coronavirus vaccine and the prospects of more U.S. economic stimulus with disappointing American jobs data. Britain approved Pfizer's COVID-19 vaccine on Wednesday, jumping ahead of the United States and Europe to become the first country to do so for the newly-developed treatment.

World equity benchmarks hovered record highs and the dollar edged off of 2-1/2-year lows on Wednesday as investors weighed the first approval of a coronavirus vaccine and the prospects of more U.S. economic stimulus with disappointing American jobs data.

Britain approved Pfizer's COVID-19 vaccine on Wednesday, jumping ahead of the United States and Europe to become the first country to do so for the newly-developed treatment. Inoculations should begin among the most vulnerable segments of its population early next week. U.S. health officials have announced plans to start vaccinating Americans as early as mid-December, once regulatory approvals are in place.

"Early vaccines will help bolster the reflation and normalcy trade, which has been the key macro theme in driving equity markets," said Neil MacKinnon, global macro strategist at VTB Capital. Yet disappointing private jobs data in the United States kept a lid on gains and helped support safe-haven assets. Employers added 307,000 jobs last month, well below the 410,000 expected by economists polled by Reuters, according to the ADP National Employment Report.

The dollar index rose 0.15%, while U.S. benchmark 10-year notes were last down 1/32 in price to yield 0.9376%, from 0.934% late on Tuesday. MSCI's gauge of stocks across the globe gained 0.05% following modest gains in Asia and mixed trading in Europe.

In morning trading on Wall Street, the Dow Jones Industrial Average fell 179.39 points, or 0.6%, to 29,644.53, the S&P 500 lost 12.27 points, or 0.34%, to 3,650.18 and the Nasdaq Composite dropped 71.33 points, or 0.58%, to 12,283.78. U.S. stock benchmarks closed at record highs on Tuesday.

"General risk sentiment is unchanged - perhaps there's a bit of consolidation today but that's understandable given where we've come from since November," said Derek Halpenny, EMEA head of research for global markets at MUFG. The dollar lost more than 2.5% of its value in November. Markets were buoyed on Tuesday after top U.S. Senate Republican Mitch McConnell said that Congress should include new coronavirus stimulus in a $1.4 trillion spending bill aimed at heading off a government shutdown in the midst of the pandemic.

U.S. President-elect Joe Biden told the New York Times his priority is getting a generous aid package through Congress even before he takes office in January. Gold rose 0.6% as signs of progress on the relief package bolstered bullion's appeal as a hedge against possible inflation.

Oil prices dipped after OPEC and its allies left markets in limbo by postponing a formal meeting to decide whether to lift output in January. U.S. crude recently fell 0.09% to $44.51 per barrel and Brent was at $47.40, down 0.04% on the day.

Oil has raced up nearly 30% over the last month.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)